Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC ; volume:1 ; number:1 ; year:2018 ; pages:44-53
Medical cannabis and cannabinoids ; 1, Heft 1 (2018), 44-53
- Creator
-
ElSohly, Mahmoud A.
Gul, Waseem
Walker, Larry A.
- DOI
-
10.1159/000489037
- URN
-
urn:nbn:de:101:1-2018062102183084606352
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- ElSohly, Mahmoud A.
- Gul, Waseem
- Walker, Larry A.
Other Objects (12)
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
![Validierte GC-MS-Bestimmung der Cannabinoide Δ9-Tetrahydrocannabinol [Delta-9-Tetrahydrocannabinol] (Δ9-THC) [(Delta-9-THC)], 11-Hydroxy-Δ9-THC [11-Hydroxy-Delta-9-THC] und 11-Nor-9-Carboxy-Δ9-THC [11-Nor-9-Carboxy-Delta-9-THC] im Serum, die Anwendung im Rahmen des EU-Projektes "ROSITA" sowie bei In-vitro-Untersuchungen zum Einfluss von Amphetaminen auf den lebermikrosomalem Δ9-THC-Metabolismus [Delta-9-THC-Metabolismus]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Validierte GC-MS-Bestimmung der Cannabinoide Δ9-Tetrahydrocannabinol [Delta-9-Tetrahydrocannabinol] (Δ9-THC) [(Delta-9-THC)], 11-Hydroxy-Δ9-THC [11-Hydroxy-Delta-9-THC] und 11-Nor-9-Carboxy-Δ9-THC [11-Nor-9-Carboxy-Delta-9-THC] im Serum, die Anwendung im Rahmen des EU-Projektes "ROSITA" sowie bei In-vitro-Untersuchungen zum Einfluss von Amphetaminen auf den lebermikrosomalem Δ9-THC-Metabolismus [Delta-9-THC-Metabolismus]
FABP1 controls hepatic transport and biotransformation of Δ9-THC
Transfer von Δ9-Tetrahydrocannabinol (Δ9-THC) und anderen Cannabinoiden aus nutzhanfhaltigen Futtermitteln in die Milch von Kühen
Photodegradation of cannabidiol (CBD) and Δ9-THC in cannabis plant material
Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling
Adult consequences of repeated nicotine and Δ9-tetrahydrocannabinol (THC) vapor inhalation in adolescent rats
#D9
D.9.
THC | THC
Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles
Chronic low-dose Δ9-tetrahydrocannabinol (THC) treatment stabilizes dendritic spines in 18-month-old mice
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
Validierte GC-MS-Bestimmung der Cannabinoide Δ9-Tetrahydrocannabinol [Delta-9-Tetrahydrocannabinol] (Δ9-THC) [(Delta-9-THC)], 11-Hydroxy-Δ9-THC [11-Hydroxy-Delta-9-THC] und 11-Nor-9-Carboxy-Δ9-THC [11-Nor-9-Carboxy-Delta-9-THC] im Serum, die Anwendung im Rahmen des EU-Projektes "ROSITA" sowie bei In-vitro-Untersuchungen zum Einfluss von Amphetaminen auf den lebermikrosomalem Δ9-THC-Metabolismus [Delta-9-THC-Metabolismus]
FABP1 controls hepatic transport and biotransformation of Δ9-THC
Transfer von Δ9-Tetrahydrocannabinol (Δ9-THC) und anderen Cannabinoiden aus nutzhanfhaltigen Futtermitteln in die Milch von Kühen
Photodegradation of cannabidiol (CBD) and Δ9-THC in cannabis plant material
Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling
Adult consequences of repeated nicotine and Δ9-tetrahydrocannabinol (THC) vapor inhalation in adolescent rats
#D9
D.9.
THC | THC
Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles
Chronic low-dose Δ9-tetrahydrocannabinol (THC) treatment stabilizes dendritic spines in 18-month-old mice
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
Validierte GC-MS-Bestimmung der Cannabinoide Δ9-Tetrahydrocannabinol [Delta-9-Tetrahydrocannabinol] (Δ9-THC) [(Delta-9-THC)], 11-Hydroxy-Δ9-THC [11-Hydroxy-Delta-9-THC] und 11-Nor-9-Carboxy-Δ9-THC [11-Nor-9-Carboxy-Delta-9-THC] im Serum, die Anwendung im Rahmen des EU-Projektes "ROSITA" sowie bei In-vitro-Untersuchungen zum Einfluss von Amphetaminen auf den lebermikrosomalem Δ9-THC-Metabolismus [Delta-9-THC-Metabolismus]
FABP1 controls hepatic transport and biotransformation of Δ9-THC
Transfer von Δ9-Tetrahydrocannabinol (Δ9-THC) und anderen Cannabinoiden aus nutzhanfhaltigen Futtermitteln in die Milch von Kühen
Photodegradation of cannabidiol (CBD) and Δ9-THC in cannabis plant material
Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling
Adult consequences of repeated nicotine and Δ9-tetrahydrocannabinol (THC) vapor inhalation in adolescent rats
#D9
D.9.
THC | THC
Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles